Real-world outcomes of dual checkpoint blockade versus PD-1/VEGF inhibitor combination as first-line therapy in metastatic renal cell carcinoma. Meeting Abstract (Web of Science)

cited authors

  • Pendyala, Manogna; Meda, Venkata Sai Abhilash; Abdalkarim, Mohammed; Khan, Waseem; Iqbal, Asif

publication date

  • June 1, 2026

webpage

published in

category

start page

  • e16550

end page

  • e16550

volume

  • 44

issue

  • 16_SUPPL